Big Gain For Ocular Therapeutix, Inc.
Mon, Feb 13, 2023 at 07:22 PM
Ocular Therapeutix, Inc. (OCUL:NASDAQ) rocketted at $5.23, representing a gain of 35.1%. On Mon, Feb 13, 2023, OCUL:NASDAQ hit a New 2-Week High of $5.23. The stock got featured on our News Catalysts scanner on Mon, Feb 13, 2023 at 09:11 AM in the 'BIOTECH' category. From Mon, Jan 30, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About Ocular Therapeutix, Inc. (OCUL:NASDAQ)
Ocular Therapeutix Inc is a biopharmaceutical company. It is engaged in developing and commercializing therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology.
Top 10 Gainers:
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 90.27%
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 43.43%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 36.76%
- Ocular Therapeutix, Inc. (OCUL:NASDAQ), 35.14%
- LuxUrban Hotels Inc Com (LUXH:NASDAQ), 33.51%
- NGL Energy Partners LP (NGL:NYSE), 28.85%
- Fastly, Inc. (FSLY:NYSE), 27.66%
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 27.1%
- Top Ships Inc. (TOPS:NASDAQ), 25.95%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 24.98%